The tweet was deleted by the author.
But we saved everything 🙂.
Monte Rosa Therapeutics will participate in the AACR2026 conference, with CEO Markus Warmuth set to join a panel of leading biopharma executives focused on proximity-induced therapies.
This move reflects the company’s ongoing commitment to pioneering next-generation therapeutic modalities. Proximity-induced therapies represent a cutting-edge approach garnering increasing attention across the biotechnology sector, and Monte Rosa Therapeutics continues to position itself at the forefront of this innovation.
Monte Rosa Therapeutics previously championed early engagement and expanded opportunities for future scientists during Women’s History Month. The company promoted new pathways for the next generation of researchers. This focus on scientific development aligns with its current efforts in proximity-induced therapies.